BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21454152)

  • 1. Hyper IgE syndrome diagnosed in early infancy by gene analysis of STAT3 mutation.
    Watarai A; Niiyama S; Morita M; Bando Y; Minegishi Y; Katsuoka K
    Eur J Dermatol; 2011; 21(2):254-5. PubMed ID: 21454152
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges of genetic counseling in patients with autosomal dominant diseases, such as the hyper-IgE syndrome (STAT3-HIES).
    Spielberger BD; Woellner C; Dueckers G; Sawalle-Belohradsky J; Hagl B; Anslinger K; Bayer B; Siepermann K; Niehues T; Grimbacher B; Belohradsky BH; Renner ED
    J Allergy Clin Immunol; 2012 Dec; 130(6):1426-8. PubMed ID: 22981789
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis.
    Schimke LF; Sawalle-Belohradsky J; Roesler J; Wollenberg A; Rack A; Borte M; Rieber N; Cremer R; Maass E; Dopfer R; Reichenbach J; Wahn V; Hoenig M; Jansson AF; Roesen-Wolff A; Schaub B; Seger R; Hill HR; Ochs HD; Torgerson TR; Belohradsky BH; Renner ED
    J Allergy Clin Immunol; 2010 Sep; 126(3):611-7.e1. PubMed ID: 20816194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of autosomal-dominant hyperimmunoglobulin E syndrome.
    Garcés P; Garcia-Martin F; Detkova D; Espanol T
    J Investig Allergol Clin Immunol; 2012; 22(2):149-52. PubMed ID: 22533245
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dominant negative STAT-3 mutations in hyper-IgE syndrome].
    Dereure O
    Ann Dermatol Venereol; 2008 May; 135(5):432. PubMed ID: 18457738
    [No Abstract]   [Full Text] [Related]  

  • 6. STAT3 signaling and the hyper-IgE syndrome.
    Levy DE; Loomis CA
    N Engl J Med; 2007 Oct; 357(16):1655-8. PubMed ID: 17881746
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel mutation in the linker domain of the signal transducer and activator of transcription 3 gene, p.Lys531Glu, in hyper-IgE syndrome.
    Kim HJ; Kim JH; Shin YK; Lee SI; Ahn KM
    J Allergy Clin Immunol; 2009 Apr; 123(4):956-8. PubMed ID: 19348930
    [No Abstract]   [Full Text] [Related]  

  • 8. [STAT3 mutation identified in patients with Hyper-IgE syndrome].
    Picard C
    Med Sci (Paris); 2008 Mar; 24(3):242-3. PubMed ID: 18334168
    [No Abstract]   [Full Text] [Related]  

  • 9. STAT3 mutation in the original patient with Job's syndrome.
    Renner ED; Torgerson TR; Rylaarsdam S; Añover-Sombke S; Golob K; LaFlam T; Zhu Q; Ochs HD
    N Engl J Med; 2007 Oct; 357(16):1667-8. PubMed ID: 17942886
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyper-IgE recurrent infection syndrome: pathogenesis, diagnosis and therapeutic management].
    Guisado Vasco P; Fraile Rodríguez G; Arechaga Uriarte S
    Rev Clin Esp; 2011 Nov; 211(10):520-6. PubMed ID: 21700278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene, in hyper-IgE syndrome.
    Papanastasiou AD; Mantagos S; Papanastasiou DA; Zarkadis IK
    Mol Immunol; 2010 Apr; 47(7-8):1629-34. PubMed ID: 20149460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel STAT3 mutation in a patient with hyper-IgE syndrome.
    Mogensen TH; Jakobsen MA; Larsen CS
    Scand J Infect Dis; 2013 Mar; 45(3):235-8. PubMed ID: 22992060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyper-IgE syndrome.
    Minegishi Y
    Curr Opin Immunol; 2009 Oct; 21(5):487-92. PubMed ID: 19717292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyper-IgE syndrome with metastatic pulmonary abscess].
    Kohno S; Hori H; Koteda T; Matsumoto T; Izumikawa K; Ishizaki T; Tomonaga A; Shigeno Y; Yamaguchi K; Hirota M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 May; 24(5):564-71. PubMed ID: 3761772
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperimmunoglobulin E syndrome with a novel STAT3 mutation.
    Anolik R; Elmariah S; Lehrhoff S; Votava HJ; Martiniuk FT; Levis W
    Dermatol Online J; 2009 Aug; 15(8):16. PubMed ID: 19891924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous manifestations of Hyper IgE syndrome.
    Minegishi Y; Saito M
    Allergol Int; 2012 Jun; 61(2):191-6. PubMed ID: 22441639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups.
    Jiao H; Tóth B; Erdos M; Fransson I; Rákóczi E; Balogh I; Magyarics Z; Dérfalvi B; Csorba G; Szaflarska A; Megarbane A; Akatcherian C; Dbaibo G; Rajnavölgyi E; Hammarström L; Kere J; Lefranc G; Maródi L
    Mol Immunol; 2008 Nov; 46(1):202-6. PubMed ID: 18706697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperimmunoglobulin E syndrome.
    Pherwani AV; Madnani NA
    Indian Pediatr; 2001 Sep; 38(9):1029-34. PubMed ID: 11568380
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced memory B cells in patients with hyper IgE syndrome.
    Speckmann C; Enders A; Woellner C; Thiel D; Rensing-Ehl A; Schlesier M; Rohr J; Jakob T; Oswald E; Kopp MV; Sanal O; Litzman J; Plebani A; Pietrogrande MC; Franco JL; Espanol T; Grimbacher B; Ehl S
    Clin Immunol; 2008 Dec; 129(3):448-54. PubMed ID: 18835223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome.
    Goussetis E; Peristeri I; Kitra V; Traeger-Synodinos J; Theodosaki M; Psarra K; Kanariou M; Tzortzatou-Stathopoulou F; Petrakou E; Fylaktou I; Kanavakis E; Graphakos S
    J Allergy Clin Immunol; 2010 Aug; 126(2):392-4. PubMed ID: 20584545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.